ANDA 83035, held by Ivax Sub Teva Pharms. Vitamin A Palmitate.
As of Nov 16, 2026, ANDA 83035 (Vitamin A), held by Ivax Sub Teva Pharms, was first approved by FDA on Dec 20, 1972, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 1972 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vitamin AEQ 50,000 UNITS BASE ยท capsule;oral | Vitamin A Palmitate | Discontinued |
| Sep 9, 1997 | Supplement 8Labeling | Approved | None posted |
| Dec 20, 1972 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters